![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/05/2909006/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/06/24/2902881/35186/en/Kura-Oncology-Reports-Preclinical-Data-Supporting-Potential-for-Menin-Inhibitor-in-Diabetes.html
https://www.globenewswire.com/news-release/2024/06/07/2895301/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/29/2889734/35186/en/Kura-Oncology-to-Participate-in-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/14/2881267/35186/en/Kura-Oncology-Completes-Enrollment-in-Registration-Directed-Trial-of-Ziftomenib-in-NPM1-Mutant-AML.html
https://www.globenewswire.com/news-release/2024/05/08/2877711/35186/en/Kura-Oncology-to-Participate-in-Bank-of-America-Securities-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/03/2875046/35186/en/Kura-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/02/2874668/35186/en/Kura-Oncology-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/25/2869528/35186/en/Kura-Oncology-to-Report-First-Quarter-2024-Financial-Results.html